IFP Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.3K | Sell |
|
|||||
|
2025
Q1 | $36.2K | Buy |
|
|||||
|
2024
Q4 | $43.7K | Buy |
|
|||||
|
2024
Q3 | $41.4K | Buy |
|
|||||
|
2024
Q2 | $12K | Buy |
|
|||||
|
2024
Q1 | $1.9K | Buy |
|
|||||
|
2023
Q4 | $473 | Sell |
|
|||||
|
2023
Q3 | $11K | Buy |
|
|||||
|
2023
Q2 | $2.73K | Buy |
|
|||||
|
2023
Q1 | $649 | Sell |
|
|||||
|
2022
Q4 | $48K | Sell |
|
|||||
|
2022
Q3 | $329K | Buy |
|
|||||
|
2022
Q2 | $314K | Hold |
|
|||||
|
2022
Q1 | $314K | Buy |
|
|||||
|
2021
Q4 | $190K | Sell |
|
|||||
|
2021
Q3 | $264K | Sell |
|
|||||
|
2021
Q2 | $247K | Buy |
|
|||||
|
2021
Q1 | $192K | Buy |
|
|||||
|
2020
Q4 | $150K | Buy |
|
|||||
|
2020
Q3 | $80K | Sell |
|
|||||
|
2020
Q2 | $65K | Buy |
|
|||||
|
2020
Q1 | $49K | Buy |
|
|||||
|
2019
Q4 | $41K | Buy |
|
|||||
|
2019
Q3 | $31K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $17K | Buy |
|
|||||
|
2018
Q3 | $12K | Buy |
|
|||||
|
2018
Q2 | $9K | Buy |
|
|||||
|
2018
Q1 | $6K | Hold |
|
|||||
|
2017
Q4 | $6K | Sell |
|
|||||
|
2017
Q3 | $60K | Buy |
|
|||||
|
2017
Q2 | $51K | Hold |
|
|||||
|
2017
Q1 | $45K | Hold |
|
|||||
|
2016
Q4 | $38K | Hold |
|
|||||
|
2016
Q3 | $42K | Sell |
|
|||||
|
2016
Q2 | $45K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $59K | Buy |
|